In this participant-driven webinar, the speakers will answer your live questions during an interactive discussion. Be sure to submit your questions in advance to help shape the direction of the discussion and get the most out of this unique opportunity.
Clinical trial management systems (CTMS) have long been the cornerstone of clinical trial operations, enabling overall program and project management. However, much has changed in the clinical environment since CTMS applications were first introduced over twenty years ago. The rising volume, complexity, and global distribution of studies have created a pressing need for greater efficiency, more transparency and collaboration, faster study execution, and reduced costs.
With so much at stake, why is it that the industry has seen little innovation in clinical trial management applications? Sponsors and CROs report systems that are costly, complex, and hard to use. As trials and resources have become more global and trial designs have become more sophisticated, sponsors and CROs are demanding a more accessible and flexible solution.
Join Ed Leftin, Ora, Inc. and Henry Galio, Veeva Systems as they discuss how a modern, cloud-based approach to CTMS has changed the landscape of trial management at Ora, Inc. by accelerating study execution and enabling end-to-end visibility across global studies.
In this webinar, you will:
- Hear how Ora improved study execution and quality by moving to a unified global system for managing clinical trials
- Learn how your CTMS can be more than a transactional system to support proactive clinical operations, enable faster trials, and accelerate insight into action
- See how a user-friendly, adaptable application can improve operational efficiencies, and streamline trial management
- Gain insight into how modernizing CTMS will reduce risk, break down silos, and improve study quality and efficiency
**Already registered for this webinar? You might also be interested in this: Discussing Today’s Challenges and the Future of Clinical Data Management.**
Henry Galio, Senior Director Vault CTMS, Veeva Systems
Henry Galio is responsible for the overall market strategy and direction of the Veeva Vault CTMS application. With over 30 years in life sciences, and 18 years in developing and implementing clinical trial systems and clinical data analytics, Henry is an expert in clinical operations software, business process optimization, and CTMS efficiency. Before joining Veeva, Henry spent 10 years working at top 10 pharma and biotech companies. He then spent 18 years working for leading software companies including Siebel, IBM, and Oracle, where he held a wide variety of consulting, architecture, sales, and strategy roles. Over the course of his career, Henry served as an advisor and implementer of CTMS solutions for hundreds of life sciences companies, and has spoken internationally on CTMS, clinical integration, clinical data warehousing, the clinical internet of things, and personalized medicine.
Ed Leftin, Manager Clinical Information Systems, Ora, Inc.
Ed Leftin brings over 25 years of healthcare IT experience in the hospital environment for project management, clinical application implementation, post-live support, and systems optimization. He joined Ora, Inc. in 2015 where he oversees the evaluation and implementation of various clinical information systems and data management platforms including EDC, eTMF, Study Start-up, CTMS, Risk-Based Monitoring, Regulatory, and publishing software.
Who Should Attend?
Senior professionals working with clinical data/clinical documentation, including:
- Trial Master File (TMF) Management
- Clinical Records Management
- Clinical Trial Management
- Clinical Operations
- Clinical Trials Associates (CTAs) / Clinical Research Associates (CRAs)
- Site Management
- Study / Study Start-up (SSU) Management
Veeva Systems Inc. is a leader in cloud based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva has more than 550 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices in Europe, Asia, and Latin America. For more information, visit www.veeva.com.